Recombinant Anti-CFB (aa 235-739) Neutralizing Antibody (V3S-0622-YC103) (CAT#: V3S-0622-YC103)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with complement Factor Bb (CFB). The antibody is able to block complement deposition in the retina.
Clonality Monoclonal
Host Species Human
Target Species Human
Epitope The epitope is located in amino acids 235-739 of complement factor Bb.
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application FuncS; Inhib
Application Notes The antibody is recommended for detection of CFB by FuncS, Inhib assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target CFB
Alternative Name BF; FB; BFD; GBG; CFAB; CFBD; PBF2; AHUS4; FBI12; H2-Bf; ARMD14; complement factor B; B-factor, properdin; C3 proaccelerator; C3 proactivator; C3/C5 convertase; glycine-rich beta-glycoprotein; properdin factor B
Gene ID 629
UniProt P00751
Related pathway Alternative complement activation pathway
Research Area Immunology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry